20 May 2013
Keywords: minster, l0, 7m, loss, line, expectations, uk
Article | 19 December 2005
The UK's Minster Pharmaceuticals, a specialist in psychiatric and neurological disorders, has posted a pretax loss of L705,000 ($1.2
million), in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 December 2005
17 May 2013
© 2013 thepharmaletter.com